Jingtai Technology announced that it has expanded its strategic cooperation with Pfizer to jointly develop a new generation of molecular simulation platform to drive new drug research and development. This cooperation aims to further integrate the accuracy of advanced physical algorithms with the speed and scalability of cutting-edge AI models, thereby comprehensively improving the efficiency, accuracy and breadth of chemical space covered by the molecular simulation platform, and significantly accelerating the discovery and development process of small molecule drugs.